SCH 206272: a potent, orally active tachykinin NK₁, NK₂, and NK₃ receptor antagonistANTHES, John C; CHAPMAN, Richard W; RIZZO, Charles et al.European journal of pharmacology. 2002, Vol 450, Num 2, pp 191-202, issn 0014-2999Article

Identification of full, partial and inverse CC chemokine receptor 3 agonists using [³⁵S]GTPγS bindingYUNTAO WAN; JAKWAY, James P; UMLAND, Shelby P et al.European journal of pharmacology. 2002, Vol 456, Num 1-3, pp 1-10, issn 0014-2999, 10 p.Article

Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway ratsCHAPMAN, Richard W; HOUSE, Aileen; JONES, Howard et al.European journal of pharmacology. 2007, Vol 571, Num 2-3, pp 215-221, issn 0014-2999, 7 p.Article

Synthesis of substituted 4(Z)-(methoxyimino)pentyl-1-piperidines as dual NK₁/NK₂ inhibitorsTING, Pauline C; LEE, Joe F; ANTHES, John C et al.Bioorganic & medicinal chemistry letters (Print). 2001, Vol 11, Num 4, pp 491-494, issn 0960-894XArticle

Synthesis and NK₁/NK₂ receptor activity of substituted-4(Z)-(methoxyimino)pentyl-1-piperazinesTING, Pauline C; LEE, Joe F; ANTHES, John C et al.Bioorganic & medicinal chemistry letters (Print). 2000, Vol 10, Num 20, pp 2333-2335, issn 0960-894XArticle

The synthesis of substituted bipiperidine amide compounds as CCR3 ligands : Antagonists versus agonistsTING, Pauline C; UMLAND, Shelby P; YUNTAO WAN et al.Bioorganic & medicinal chemistry letters (Print). 2005, Vol 15, Num 12, pp 3020-3023, issn 0960-894X, 4 p.Article

Structure-activity relationships of oxime neurokinin antagonists: Oxime modificationsREICHARD, Gregory A; SPITLER, James; ASLANIAN, Robert et al.Bioorganic & medicinal chemistry letters (Print). 2002, Vol 12, Num 5, pp 833-836, issn 0960-894XArticle

The synthesis of substituted fluorenes as novel non-imidazole histamine H₃ inhibitorsTING, Pauline C; LEE, Joe F; ALBANESE, Margaret M et al.Bioorganic & medicinal chemistry letters (Print). 2002, Vol 12, Num 18, pp 2643-2646, issn 0960-894XArticle

Pharmacology of a potent and selective inhibitor of PDE4 for inhaled administrationCHAPMAN, Richard W; HOUSE, Aileen; ASLANIAN, Robert et al.European journal of pharmacology. 2010, Vol 643, Num 2-3, pp 274-281, issn 0014-2999, 8 p.Article

Identification of a novel 1'-[5-((3,5-dichlorobenzoyl)methylamino)-3-(3,4-dichlorophenyl)-4-(methoxyimino) pentyl]-2-oxo-(1,4'-bipiperidine) as a dual NK₁/NK₂ antagonistTING, Pauline C; LEE, Joe F; SHIH, Neng-Yang et al.Bioorganic & medicinal chemistry letters (Print). 2002, Vol 12, Num 16, pp 2125-2128, issn 0960-894XArticle

The synthesis and structure-activity relationship of 4-benzimidazolyl-piperidinylcarbonyl-piperidine analogs as histamine H₃ antagonistsTING, Pauline C; LEE, Joe F; ANTHES, John C et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 17, pp 5004-5008, issn 0960-894X, 5 p.Article

The synthesis and structure―activity relationship of pyridazinones as glucan synthase inhibitorsTING, Pauline C; RONGZE KUANG; BLACK, Todd A et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 6, pp 1819-1822, issn 0960-894X, 4 p.Article

Discovery of a Novel Class of Orally Active Antifungal β-1,3-D-Glucan Synthase InhibitorsWALKER, Scott S; YIMING XU; NORRIS, Christine et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 11, pp 5099-5106, issn 0066-4804, 8 p.Article

SAR studies of pyridazinone derivatives as novel glucan synthase inhibitorsGANG ZHOU; TING, Pauline C; ZYCH, Andrew J et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 10, pp 2890-2893, issn 0960-894X, 4 p.Article

The optimization of pyridazinone series of glucan synthase inhibitorsRONGZE KUANG; HEPING WU; ZYCH, Andrew J et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 16, pp 5268-5271, issn 0960-894X, 4 p.Article

The synthesis of substituted bipiperidine amide compounds as CCR3 antagonistsTING, Pauline C; LEE, Joe F; JAKWAY, James et al.Bioorganic & medicinal chemistry letters (Print). 2005, Vol 15, Num 5, pp 1375-1378, issn 0960-894X, 4 p.Article

Discovery of oxazole-based PDE4 inhibitors with picomolar potencyRONGZE KUANG; SHUE, Ho-Jane; JIANHUA CAO et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 7, pp 2594-2597, issn 0960-894X, 4 p.Article

Lead optimization of a sulfonylurea-based piperazine pyridazinone series of glucan synthase inhibitorsZYCH, Andrew J; LAM, Sang Q; WAINHAUS, Samuel et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 14, pp 4896-4899, issn 0960-894X, 4 p.Article

Identification of a novel, orally bioavailable histamine H₃receptor antagonist based on the 4-benzyl-(1H-imidazol-4-yl) templateASLANIAN, Robert; MUTAHI, Mwangi W; ROSENBLUM, Stuart B et al.Bioorganic & medicinal chemistry letters (Print). 2002, Vol 12, Num 6, pp 937-941, issn 0960-894XArticle

Discovery of a highly potent series of oxazole-based phosphodiesterase 4 inhibitorsKUANG, Rongze; SHUE, Ho-Jane; ASLANIAN, Robert et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 18, pp 5150-5154, issn 0960-894X, 5 p.Article

Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H₃ receptor antagonistsBERLIN, Michael; TING, Pauline C; DUGUMA, Luli et al.Bioorganic & medicinal chemistry letters (Print). 2006, Vol 16, Num 4, pp 989-994, issn 0960-894X, 6 p.Article

The discovery of novel tartrate-based TNF-α converting enzyme (TACE) inhibitorsROSNER, Kristin E; ZHUYAN GUO; LIWU HONG et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 3, pp 1189-1193, issn 0960-894X, 5 p.Article

Structure and activity relationships of tartrate-based TACE inhibitorsDANSU LI; POPOVICI-MULLER, Janeta; MAZZOLA, Rob et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 16, pp 4812-4815, issn 0960-894X, 4 p.Article